This analysis highlights how regulatory systems affect asset-backed securities in China and the USA, indicating key risks.
The paper will compare and contrast the asset-backed securities, which are financial products in the shadow banking system in China and the USA. An asset-backed security (ABS) is a financial investment collateralized by an underlying pool of assets. Due to different regulatory systems in different countries, the working mechanism and the potential risks for purchasing asset-backed securities will vary from country to country. Our analysis compares the working mechanism of asset-backed securities in China and the USA, such as classification, credit rating, and investor base. We investigate the different regulatory system of asset-backed securities in China (the so-called New Asset Management Regulations) and USA (the Dodd-Frank Act) in order to find out the different potential risks that are brought by the securities. Based on our research, we evaluate the asset-backed securities including long-term effect vs short term effect and pros and cons on different stakeholders.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: